The plasma levels of IL-17A in the CHC-SF and CHC-NSF groups were lower in comparison with the group of patients with NASH (p = 0.0035, p = 0.000, respectively). The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.